On April 7, 2014, Roche announced the acquisition of IQuum, Inc. The acquisition provides Roche with access to IQuum’s Laboratory-in-a-tube (Liat) System, which enables healthcare workers to perform rapid molecular diagnostic testing in a point of care setting, closer to patients and with minimal training. The Liat Analyzer and Liat Influenza A/B Assay, the first test available for use on the system, produce reliable and accurate lab-like results and are CE marked and FDA cleared.
The website dedicated to the Liat system is currently in development and will be reintroduced shortly under the cobas® brand of products and services. We look forward to extending the value of molecular testing to point-of-care environments in the very near future.